Label: NAPROXEN tablet
-
NDC Code(s):
65841-676-01,
65841-676-10,
65841-677-01,
65841-677-05, view more65841-677-10, 65841-678-01, 65841-678-05, 65841-678-10
- Packager: Zydus Lifesciences Limited
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated September 27, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Medication Guide: HTML
- Official Label (Printer Friendly)
- MEDICATION GUIDE
- SPL MEDGUIDE
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
NAPROXEN
naproxen tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65841-676 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NAPROXEN (UNII: 57Y76R9ATQ) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN 250 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) MAGNESIUM STEARATE (UNII: 70097M6I30) POVIDONE (UNII: FZ989GH94E) Product Characteristics Color YELLOW Score 2 pieces Shape ROUND Size 10mm Flavor Imprint Code ZE10 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65841-676-01 100 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 2 NDC:65841-676-10 1000 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA078620 11/09/2017 NAPROXEN
naproxen tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65841-677 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NAPROXEN (UNII: 57Y76R9ATQ) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN 375 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) MAGNESIUM STEARATE (UNII: 70097M6I30) POVIDONE (UNII: FZ989GH94E) Product Characteristics Color YELLOW (yellow) Score no score Shape CAPSULE Size 14mm Flavor Imprint Code ZE9 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65841-677-01 100 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 2 NDC:65841-677-05 500 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 3 NDC:65841-677-10 1000 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA078620 11/09/2017 NAPROXEN
naproxen tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65841-678 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NAPROXEN (UNII: 57Y76R9ATQ) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN 500 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) MAGNESIUM STEARATE (UNII: 70097M6I30) POVIDONE (UNII: FZ989GH94E) Product Characteristics Color YELLOW Score 2 pieces Shape CAPSULE Size 16mm Flavor Imprint Code ZE8 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:65841-678-01 100 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 2 NDC:65841-678-05 500 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 3 NDC:65841-678-10 1000 in 1 BOTTLE; Type 0: Not a Combination Product 11/09/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA078620 11/09/2017 Labeler - Zydus Lifesciences Limited (918596198) Registrant - Zydus Lifesciences Limited (918596198) Establishment Name Address ID/FEI Business Operations Zydus Lifesciences Limited 918596198 ANALYSIS(65841-676, 65841-677, 65841-678) , MANUFACTURE(65841-676, 65841-677, 65841-678)
